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Abstract 
 
 
MICROBIAL DNA RECEPTOR EXPRESSION IN CHRONIC PERIODONTITIS  
 
By Stephanie C. Voth, DDS 
 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science 
at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2013 
 
Major Director: S. Esra Sahingur, DDS, MS, PhD 
Associate Professor, Department of Periodontics 
 
 
AIM:  The aim of this study was to determine the expression of microbial nucleic acid receptors 
including Toll like receptor 9 “TLR-9”, DNA-dependent activator of interferon-regulatory 
factors “DAI” and absent in melanoma “AIM-2” in chronic periodontitis (P) versus healthy (H) 
tissues. 
METHODS:  33 chronic periodontitis (P) and 27 periodontally-healthy (H) gingival biopsies 
were included. The gene and protein expression for each receptor was determined using real-time 
quantitative PCR and immunohistochemistry. 
RESULTS: Our results revealed statistically significant up-regulation of TLR-9 (p<0.006) and 
DAI (p<0.001) gene expression in P tissues compared to H sites. We were also able to 
demonstrate significant correlation among three DNA receptors (p<0.05). Immunohistochemistry 
further confirmed the expression of DNA sensors in gingival tissues.   
   
CONCLUSION: This study highlights a possible role for nucleic acid sensing in periodontal 
inflammation. Further investigations will determine whether cytoplasmic receptors and their 
ligands can be targeted to improve clinical outcomes in periodontitis. 
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CHAPTER 1 Introduction 
 
  
 Periodontitis is a complex, multifactorial disease that is initiated by an interaction between 
periodontal pathogens and host immune cells.
1
  Specific bacteria activate the host immune 
response that aim to control the pathogens while simultaneously causing inflammation and 
destruction of the periodontal tissues.
2,3
 The pathogenesis of periodontal disease has evolved 
further with the knowledge that environmental and genetic factors influence the disease process 
via modifying the expression of genes activated by bacteria and their byproducts.
4
  The dynamic 
relationship between bacteria, genetics and environmental elements supports a biologic systems 
approach to modeling periodontal disease with the ultimate goal of defining expression patterns in 
the tissues with respect to environmental and genetic conditions along with corresponding clinical 
parameters.
4
 
 The “biologic systems model” is comprised of different components which interact with 
one another to produce the clinical phenotype (i.e. the clinical presentation of disease).
5
 The 
outer-realm of this model is the subject level which involves individual unique exposures such as 
the characteristics of the bacterial biofilm, health conditions (e.g. diabetes) and environmental 
factors (e.g. cigarette smoke). In this model, an individual’s genetics interacts with the subject-
level components thus impacting the host’s response to the bacterial biofilm. The biologic 
phenotype is associated with the clinical phenotype via cellular and molecular responses that 
involve inflammatory biomarkers.
6
 This model suggests that identifying diagnostic biomarkers is 
 2 
important since individuals may have similar clinical presentations but dramatically different 
predisposing factors and thus may respond differently to the same treatment.
7
  Thus, by using the 
biologic systems approach to defining periodontal disease, homogenous diagnostic categories can 
be established, diagnostic biomarkers can be measured, all leading to more accurate prognoses 
and expected therapy responses.
6
 
 Tanerella forsythensis, Porphyromonas gingivalis (P. gingivalis) and Treponema 
denticola are putative periodontal pathogens that have been highly implicated in periodontal 
disease. They are all members of the “red complex” and frequently occur together in subgingival 
plaque biolfilms.
8 
 Microbiologic identification has been deemed useful for disease monitoring 
and treatment guidance (i.e. antibiotic therapy) but does not help to predict future periodontal 
disease progression.
9 
While particular periodontal bacteria are required to initiate disease, they are 
only sufficient to cause disease in a susceptible host.
10
  The host immune system is typically 
protective against pathogens but can be simultaneously destructive or dysregulated when it is 
overwhelmed by a bacterial challenge in susceptible individuals. Certain microorganisms have the 
capacity to evade the host immune response by escaping recognition, phagocytosis and even 
exerting immunosuppressive effects.  Identifying microbes, particularly the evading type, with 
certain biomarkers may enhance the ability to predict future disease progression.
11
 
 Genomics can be relevant in identifying those who are predisposed to periodontitis and 
samples for testing can be obtained via blood, tissue, saliva, gingival crevicular fluid or dental 
plaque biofilm. Single nucleotide polymorphisms in the IL-1 gene have been researched 
extensively and it has been found that individuals who have both the IL-1α +4845 and IL-1β 
+3954 are predisposed to severe chronic periodontitis via a hyperinflammatory response to 
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periodontal pathogens.
12
  Socransky et al. studied IL-1 genotype-positive and negative patients 
and found that those who were IL-1 genotype-positive had higher levels of “red complex” 
bacteria.
13 
 Thus, genetic polymorphisms can help to determine if a patient has an increased 
susceptibility to chronic periodontal disease. 
 Traditional methods for diagnosing periodontal disease include measurements of probing 
depth, clinical attachment loss and bleeding on probing, plaque levels, and bone loss.
14
  One of 
the drawbacks of such measurements to diagnose disease is that they account for disease history.  
New research focuses on identifying and quantifying periodontal disease and risk with biomarkers 
at the cellular and molecular level.
15
 Biomarkers that can be identified via plaque biofilm, 
gingival crevicular fluid (GCF) and saliva include microbial factors (i.e. periodontal pathogens), 
host response factors (i.e. IL-1β) and connective tissue breakdown products (i.e. collagen 
telopeptides).  At the cellular level of biomarkers, inflammatory cell activation (i.e. neutrophils) 
of the innate immune system via bacteria or their byproducts ultimately leads to osteoclast type 
cell activation and alveolar bone loss.  Pyridinoline cross-linked carboxyterminal telopeptide of 
type I collagen (ICTP) is released into the GCF during this process of bone resorption and is an 
example of a measureable biomarker of periodontal disease. On the other hand, at the molecular 
level, the activation of toll-like receptors (TLRs) can also be determined to identify susceptibility 
or disease activity. While TLRs represent possible targets as biomarkers of periodontal disease, 
more research is needed to determine such effects.
15
 
 It has been well documented  in the literature that pathogen associated molecular pattern 
(PAMP) recognition via host pattern recognition receptors (PRRs) activates intracellular signaling 
cascades leading to periodontal inflammation through the up-regulation of cytokines, chemokines 
and costimulatory molecules.
 
TLRs represent a type of host PRR and are the mammalian
 4 
homologues of Toll first discovered in Drosophilia as a gene that functions in immunity.
16, 17, 18  
TLRs are comprised of an extracellular leucine-rich repeat (LRR) domain and an intracellular 
Toll/interleukin (IL)-1 receptor (TIR) domain.
19 
 The LRR can accommodate a variety of PAMP 
binding interactions and signal tranductions. While microbial products (i.e. bacterial LPS) 
comprise the majority of TLR ligands, other ligands include flagellin, bacterial DNA as well as 
viral RNA and DNA.
20
   Specifically, P. gingivalis fimbrae signal through TLR2 or TLR4 which 
activates a signaling pathway that mediates production of proinflammatory cytokines such as IL-6 
and TNF-α which is different than the signaling pattern stimulated by P. gingivalis LPS.21   TLRs 
in humans are either extracellular (TLR -1, -2, -4, -5, -6, -10), mainly recognizing pathogenic 
structural components such as LPS, or intracellular (TLR -3, -7, -8, -9), specializing in the 
recognition of foreign or self RNA and DNA.
22, 23 
 While the extracellular receptors have been 
well studied, limited literature to date has examined intracellular PRR involvement in periodontal 
pathogenesis.  
 TLRs require co-receptors and adaptor molecules for pathogen recognition and 
downstream signaling. For example, TLR4 is influenced by co-receptor MD-2 which directly 
interacts with LPS
24
 and in the CD14-dependent signaling pathway, CD14 is responsible for 
stimulating the TRAM-TRIP pathway which amplifies the production of TNF-α and Il-6 via NF- 
κB activation.25  The engagement of adaptor molecules such as myeloid differentiation factor-99 
(MyD88) is necessary for proinflammatory cytokine production for all TLRs except TLR3. 
Interestingly, MyD88-dependent signaling of the intracellular TLRs -7,-8, and -9 can either 
induce NF- κB or type-I interferon (IFN) production which are proinflammatory and anti-
inflammatory responses respectively.
20 
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 Nucleic acids, such as DNA and RNA are typically sequestered within bacteria. During 
infection or inflammatory processes, however, they can be released and become detected by 
specific intracellular receptors.
26
 Recognition of bacterial DNA by the host immune system leads 
to activation of distinct signaling pathways and immune responses through various receptors that 
may be operant and important in periodontal inflammation and pathology.  Bacterial nucleic acids 
(bDNA) are recognized mainly through the intracellular TLR-9
27
 thereby activating the NF-κB 
and MAPK signaling pathways that stimulate pro-inflammatory and anti-inflammatory activities 
depending on cell type.
28  Sahingur et al. demonstrated that, in response to periodontal bDNA, 
human monocytic cells (THP-1) produce pro-inflammatory cytokines via TLR-9 and the NF-κB 
signaling pathway.
29
  Other investigators also determined similar responses in primary human 
gingival fibroblasts
30
 and mouse macrophage cell lines.
31
 
  Supporting a role of TLR9 in periodontal disease, it has been shown that gene expression 
of this receptor is increased in periodontally-diseased tissues compared to healthy tissues.
32 
Differential expression of TLR -1 through -9 between periodontitis patients and healthy controls 
amongst their gingival and connective tissues has also been demonstrated.
33  Two recent studies 
reported differences in the distribution of single nucleotide polymorphisms located in the TLR9 
promoter region in subjects with chronic periodontitis versus periodontally healthy individuals.
34, 
35
  These polymorphisms may explain the differences in host susceptibility to periodontitis, hence 
further supporting a possible role of intracellular DNA receptors in periodontal disease 
pathogenesis.  
 Similar to TLR-3, 7, 8 and 9, absent in melanoma (AIM)2, is a recently identified 
intracellular receptor for cytosolic bacterial, viral and host double stranded DNA (dsDNA) that 
undergoes a series of reactions resulting in the formation of an inflammasome that generates the 
 6 
pro-inflammatory cytokine IL-1β.36, 37  Nucleotide binding oligomerization domain-like receptor 
(NLR) inflammasomes are intracellular PRRs that are activated by cell stress, bacteria or viruses 
and consist of the NLRP3 ‘sensor’, the caspase-1 ‘effector’ and the apoptotic speck protein 
containing a C-terminal caspase recruitment domain (APC) ‘adaptor’ which links NLRP3 and 
caspase-1.
38-42
  AIM2 is a non-NLR inflammasome which recognizes different PAMPs than 
NLRP3, including cytosolic double-stranded DNA, but like NLRP3, AIM2 inflammasomes 
oligomerize with APC and caspase-1 leading to the activation of intracellularly stored Il-1β.36  In 
a study by Bostanci et al. 2011, AIM2 expression was up-regulated by low concentrations and 
down-regulated at higher concentrations of P. gingivalis.
43
   These pathogenic mechanisms of 
dampening the immune response highlight the covertness of P. gingivalis and its ability to evade 
the host innate immune system allowing for its continual survival.  
 DNA-dependent activator of IFN-regulatory factors (DAI), a cytosolic receptor for 
microbial, viral or host derived DNA, activates the innate immune system via the NF-κB 
pathway.
44, 45
 DAI induces IRF3 and NF- κB transcription factors to produce type I IFN (IFNα 
and IFNβ).45 The mechanism of DAI-mediated NF- κB activation involves adaptor receptor-
interacting protein kinase (RIP)1 and RIP3.
46
 The type 1 IFN cytokines have immunomodulatory, 
antiviral and antitumoral properties and their production initiates a positive feedback loop that 
amplifies the immune response.
47-49
 
 Several studies have linked periodontal disease with systemic inflammation and 
conditions such as adverse pregnancy outcomes
50
, cardiovascular (CVD)
51
, respiratory
52
, 
autoimmune diseases
53
, diabetes
54
 and cancer
55
. The involvement of nucleic acid activated 
receptors and signaling pathways in the pathogenesis of several systemic conditions, including 
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viral and bacterial infections, autoimmune diseases and cancer, have been documented and are 
under active investigation.
56 
 Periodontal bDNA presence in atheromatous plaques
57, 58 
as well as 
in synovial fluid and serum samples of refractory rheumatoid arthritis patients
59
 may be the means 
linking periodontal disease with these systemic diseases. Hence, the knowledge gained from this 
proposal may not only lead to alternative treatment strategies to control periodontal inflammation, 
but also help to reveal new biological pathways linking periodontitis with systemic conditions. 
Furthermore, this will be the first study that will determine DAI and AIM-2 expression in 
periodontally diseased tissues as compared to healthy tissues 
 Considering the constant presence of nucleic acids in the periodontal tissues and within 
dental biofilms, bacterial DNA-initiated immune responses represent alterative pathways to 
periodontal inflammation that need further investigation using well defined clinical samples via 
in vivo studies. Findings from this study and similar research may lead to novel diagnostic tests 
that can determine and evaluate periodontal disease activity, chance for disease progression and 
response to therapy.  It is hypothesized that the expression of intracellular receptors, specifically 
in this study TLR-9, DAI and AIM-2, will be increased in periodontally diseased sites. 
Therefore, the aim of this study is to determine and compare the expression of intracellular PRRs 
for DNA, specifically TLR9, DAI and AIM2 in the gingival tissues of chronic periodontitis 
patients and periodontally-healthy subjects. 
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CHAPTER 2 Methods 
 
Patients and Tissue Samples 
 
 33 chronic periodontitis patients (Ps) and 27 healthy controls (Cs) who consented to 
participate in the study were included. The included subjects (age range 20-79 y.o.) were 
systemically healthy with at least 20 natural teeth present. The periodontitis subjects had pocket 
depths (PD) >4mm, clinical attachment loss (CAL) >2mm, BOP and radiographic evidence of 
alveolar bone loss of at least two teeth (excluding 3
rd
 molars) per quadrant. These patients were 
treated with initial periodontal therapy including scaling and root planing and oral hygiene 
instruction. At the reevaluation appointment 4-6 weeks after initial therapy, Ps exhibiting sites 
with PD >4mm and persistent bleeding on probing (BOP) in at least one quadrant that needed 
further surgery as part of their definitive treatment plan were recruited for the study.  Cs were 
recruited for the study if they had no sites with PD ≥ 4mm, CAL > 2mm nor radiographic 
evidence of alveolar bone loss and had teeth that were to undergo crown lengthening or 
extraction.  
 Subjects were excluded from the study if they were smokers (or reformed smoker if quit 
< 5 years ago), had a history of alcoholism, hepatitis, AIDS or HIV, recent radiation therapy, 
diabetes, uncontrolled hypertension, use of immunosuppressive medications, antibiotic or 
NSAID use within the past 6 months, or were pregnant. Patients were also excluded if they had a 
history of previous periodontal surgery or localized drug delivery at the site to be sampled.  
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 One gingival biopsy was collected from each predetermined site, bisected half 
longitudinally and placed into two labeled vials containing either RNAlater® (Qiagen) or 10% 
Formalin to be used in gene expression and immunohistochemistry assays, respectively. 
 The experimental protocol was approved by the Institutional Review Board of Virginia 
Commonwealth University and informed consent was obtained from all patients.  
 
RNA Isolation and Real-Time Quantitative Polymerase Chain Reaction 
 
 Isolation of total RNA from the gingival tissues was accomplished using the Qiagen 
RNeasy plus mini kit with on-column Dnase digestion according to manufacturer’s instructions. 
The RNA concentration was measured using the Nano Drop (ND-1000) Spectrometer. 
Subsequently complementary DNA (cDNA) was generated from the isolated RNA using the 
High capacity cDNA Reverse Transcriptase kit (Applied Biosystems) according to the 
manufacturer’s instructions. Quantitative real time PCR then amplified the synthesized cDNA to 
determine the gene expression of TLR-9, AIM2 and DAI receptors using specific primers (IDT 
Inc.) (Table 1) labeled with SYBR green (Qiagen SYBR Green Rox™).  The specific thermal 
cycling conditions were 25 C for 10 min followed by 37C for 120 min, 85C for 5 seconds and 
4C overnight.  For an internal control, glyceraldehyde 3-phosphate-dehydrogenase (GAPDH) 
mRNA was used.  
 
Immunohistochemistry 
 
 The expression of TLR-9, AIM-2 and DAI in the gingival tissues was further confirmed 
using immunohistochemistry (N=5 periodontitis and N=5 healthy samples).  The deparaffinized 
tissue sections from periodontitis and healthy sites were first treated with primary polyclonal 
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antibodies (rabbit anti-human TLR-9, rabbit anti-human AIM-2 and rabbit anti-human DAI, 
(Abcam) and then the tissues were further treated with a secondary polyclonal anti-rabbit IgG 
antibody (Biotin-Avadin system, Vectastain Elite ABC Kit, Vector Laboratories). Slides were 
then stained using DAB solution (Vector Labs) and Hematoxylin Counterstain (Sigma) before 
dehydrating and permanent mounting. Negative controls were run in parallel with 
immunostaining using a secondary antibody only. For immunohistochemistry, the staining 
intensity was compared between healthy versus diseased tissue samples using a microscope 
(Nikon Eclipse E400). 
 
Statistical Analysis 
 
 The difference in clinical parameters and the demographic variables between the two 
groups was compared using an unpaired student t-test and a chi-square test (Table 2). Gene 
expression levels of different receptors between healthy and diseased tissues were analyzed using 
the ddCT (Relative Quantitation) Study Program (7500 Fast System SDS Software, Applied 
Biosystems) after adjusting the values relative to the housekeeping gene (GAPDH). The gene 
expression level is represented as a fold change, and a minimum of a 2-fold difference between 
diseased and healthy tissues was required for further statistical analysis using ANCOVA which 
adjusted for the confounders of race, age and gender. The Spearman test was used to determine 
the correlations between each receptor (Table 3). The p value was set at <0.05.  
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CHAPTER 3 Results 
 
 
 Table 2 summarizes the demographic characteristics of the study population, including 
age, gender and race as well as the clinical parameters at the sampled sites. There was a 
significant difference between mean age (47.6 y.o. ± 2.70 in H versus 58.8 y.o. ± 2.44 in P) 
(p<0.05), gender distribution (7 males and 20 females in H versus 18 males and 15 females in P) 
(p<0.05) and the clinical parameters among groups. The statistical analyses were adjusted for all 
the confounders.  
Gene Expression of Pattern Recognition Receptors in Gingival Tissues 
 33 periodontal and 27 healthy patients were included in the final analysis. Figure 1 shows 
the mRNA expression of pattern recognition receptors (TLR-9, AIM2 and DAI) in gingival 
tissues of subjects with and without periodontitis. Specifically, the mRNA expression of TLR9, 
DAI and AIM2 was increased 7.8-fold, 2-fold and 5.6-fold in periodontally-diseased gingival 
tissues compared to healthy sites, respectively. The relative expression levels of the receptors in 
periodontitis tissues compared to healthy sites are shown in Table 3. A statistically significant 
up-regulation of TLR9 (p<0.006) and DAI (p<0.001) in periodontally-diseased tissues compared 
to healthy sites was shown after adjusting for confounding factors. Although AIM2 did not show 
a significant change between diseased versus healthy tissues, our analysis indicates significant 
correlations between AIM2 and DAI as well as TLR9 (Table 4). This may suggest that multiple 
receptors interact with each other to mount an appropriate immune response. 
 12 
Immunohistochemical Analyses of TLR-9, AIM2 and DAI in Gingival Tissues 
 To provide further substantiation of our gene expression data, immunohistochemistry was 
performed to confirm protein expression of DAI, AIM2 and TLR9 in the periodontally-diseased 
and healthy tissues.  This was done by staining tissue sections prepared from 5 healthy and 5 
periodontitis patients using antibodies that recognize these receptors. Figure 2 shows 
representative images from these tissue samples.  While AIM2 and DAI had low constitutive 
expression in the gingival epithelium, they were both involved in the underlying connective 
tissue and elevated in the periodontally-diseased tissue samples. TLR9 staining however, while 
strong in the healthy epithelial cells, was elevated in tissues from periodontitis patients and was 
also prominent in the connective tissue. Thus, the immunohistochemical data confirm expression 
of AIM2, DAI and TLR9 in periodontally diseased tissues.  
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Table 1 – Pattern Recognition Receptors and Primers 
 
Symbol    Gene name Sequence (5'-3') 
GAPDH Glyceraldehyde-3-phosphate 
dehydrogenase 
F:  5’-CAA TGA CCC CTT CAT TGA CC-3’ 
    R:  5'-TTG ATT TTG GAG GGA TCT CG-3’ 
AIM2 Human absent in melanoma 2 F:  5'-CAG AAA TGA TGT CGC AAA GCA A-3' 
    R:  5’-TCA GTA CCA TAA CTG GCA AAC AG-3' 
DAI Human DNA-dependent activator 
of IFN-regulatory factor 
F:  5'-AAC ATG CAG CTA CAA TTC CAG A-3' 
  R:  5'-AGT CTC GGT TCA CAT CTT TTG C-3' 
TLR9 Human toll-like receptor 9 F:  5'-CTG CCA CAT GAC CAT CGA G-3' 
  R:  5’-GGA CAG GGA TAT GAG GGA TTT G-3' 
 
 
 
 
 
Table 2 – Study Population Demographics 
 
 Healthy (H) Patient (P) p-value 
Gender (n) (Male/Female) 7/20 18/15 p < 0.05 
Age (mean ± SD) 47.6 ± 2.70 68.8 ± 2.44 p < 0.05 
Race (n) 
(Caucasian/Black/Asian/Hispanic) 
22/4/0/1 21/9/3/0 p > 0.05 
Periodontal Probing Depth (mm) 
(mean ± SD) 
1.652 ± 0.714 7.121 ± 1.386 p < 0.001 
Clinical Attachment Loss (mm) 
(mean ± SD) 
0.682 ± 0.56 7.303 ± 1.928 p < 0.001 
 
 
 
 
 
Table 3 - Relative Expression Levels of Pattern Recognition Receptors in Periodontitis 
 
Pattern Recognition 
Receptors 
Gene Expression  
(Fold increase in periodontitis) 
p-value 
AIM2 2.0-fold N.S.* 
DAI 5.6-fold p < 0.001 
TLR9 7.8-fold p < 0.006 
*N.S. (Non-significant) 
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Table 4 – Correlation between Pattern Recognition Receptors 
 
Pattern Recognition Receptors Spearman p P-value 
TLR9 & DAI 0.8517 <.0001 
DAI & AIM2 0.6837 <.0001 
TLR9 & AIM2 0.6086 <.0001 
 
 
 
 
 
 
 
 
 
 
Figure 1 – Pattern Recognition Receptor Expression - Relative mRNA expression of pattern 
recognition receptors in healthy (H) and periodontally-diseased (P) tissues. The results are 
reported as fold-induction relative to H (=1) after normalization to GAPDH. Asterisks indicate 
statistically significant differences in receptor expression between H and P tissues. *p<0.001; 
**p<0.006 
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Figure 2 – Immunohistochemical detection of pattern recognition receptor expression. 
Tissue sections from healthy subjects (H) and periodontitis patients (P) were immunostained 
with the indicated antibodies (upper panels), as described in the Methods section. Lower panels: 
negative controls. Original magnification, x40. 
 
 
 
 
 
 
 
 
 
 
 
 16 
 
 
 
 
 
CHAPTER 4 Discussion 
 
 
 This is the first study reporting increased DAI and AIM2 expression in periodontal 
tissues and also confirms and extends previous evidence that TLR-9 expression is enhanced in 
periodontally diseased tissues at both the mRNA and protein levels.
60
  While many of the studies 
that investigate nucleic acid sensing in the context of periodontal inflammation are in vitro
28, 29, 31 
in nature, there are only a few clinical reports that have addressed the role of TLR-9 in 
periodontitis.
32, 33
 Similar to this study, Rojo-Botella et al. 2012 found the expression levels of 
TLR9 to be higher in all periodontal patients than in healthy individuals and that the expression 
of TLR9 is positively regulated with the severity of periodontal disease.
61
  Recent studies have 
also shown that polymorphisms exist in TLR9 promoter regions in subjects with chronic 
periodontitis which may explain the differences in host susceptibility to periodontal disease.
34, 35
  
These studies together lend credence to TLR9 recognition of pathogen-derived nucleic acids 
having an essential role in triggering the immune mechanisms involved in periodontal disease.  
 In terms of immunohistochemistry, this study provides the first evidence regarding the 
expression of AIM2 and DAI proteins as well as extended evidence of the expression of TLR9 
protein in periodontal tissues. This study is also in agreement with the study by Belken et al. in 
which the connective tissue had consistently higher TLR9 expression than the epithelial layer 
within the periodontitis group compared to the healthy group.
33
 There was an overall increase in 
the staining intensity and distribution of TLR9 both in the epithelium and connective tissue in the 
periodontitis sites compared to healthy tissues. Since nucleic acid receptors have been found to 
 17 
be expressed in gingival epithelial cells, gingival fibroblasts, monocytes/macrophages and 
dendritic cells, it would be important to design future clinical studies similar to this one that 
determine the specific cell types expressing each DNA receptor. This would allow for a better 
understanding of the pathogenesis of periodontitis and help to determine which cells to target 
therapeutically.  
 AIM2, while showing increased expression, was not statistically different between groups 
as was TLR9 and DAI.  However, we showed in our study that AIM2 was significantly 
correlated to DAI and TLR9. This lends evidence to multiple receptors interacting with each 
other to mount an appropriate immune response as has been shown in a study by Brown et al.
62
 
 While bacterial etiology of periodontitis is well accepted, the contribution of viruses to 
periodontal disease pathology has also been supported.
63, 64
 Since TLR9
65
, DAI
65
 and AIM2
36
 all 
recognize both bacterial DNA as well as the DNA of viruses, it is possible that the increased 
expression of nucleic acid receptors in periodontitis patients may have been partly due to their 
ability to recognize viruses within the oral tissues as well. Future investigations are needed to 
differentiate the effect of viruses and bacteria on the upregulation of these receptors within 
gingival tissues of periodontally diseased versus healthy sites.  
 In conclusion, it was found that DAI and TLR9 were significantly upregulated in 
periodontally diseased tissues as compared to healthy tissue samples. In keeping with the 
multifactorial nature of periodontal disease pathogenesis these receptors’ up-regulation may be a 
result of inflammation in response to pathogens that further augments the immune response or 
their higher expression may represent another biological pathway that directly initiates a response 
alone or in cooperation with other innate receptors leading to persistent inflammation. Further 
 18 
studies are needed to fully understand the contribution of intracellular DNA sensors in 
periodontitis that may lead to alternative treatment strategies to control periodontal inflammation.  
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